As a cellular bile acid sensor, farnesoid X receptor (FXR) participates in regulation of bile acid, lipid and glucose homeostasis, and liver protection. Clinical results have validated FXR as therapeutic target in hepatic and metabolic diseases. To date, potent FXR agonists share a negatively ionizable function that might compromise their pharmacokinetic distribution and behavior. Here we report the development and characterization of a high-affinity FXR modulator not comprising an acidic residue.
As a cellular bile acid sensor, farnesoid X receptor (FXR) participates in regulation of bile acid, lipid and glucose homeostasis, and liver protection. Clinical results have validated FXR as therapeutic target in hepatic and metabolic diseases. To date, potent FXR agonists share a negatively ionizable function that might compromise their pharmacokinetic distribution and behavior. Here we report the development and characterization of a high-affinity FXR modulator not comprising an acidic residue.
In situ synthesis of manganese(III) complexes under control: Crystal structure and magnetic properties
作者:Shuai Ding、Yu-Fei Ji、Min-Yan Kang、Chun-Fang Du、Zhi-Liang Liu、Cai-Ming Liu
DOI:10.1016/j.inoche.2012.04.022
日期:2012.7
Abstract Three new manganese(III) compounds have been synthesized via in situ ligand transformation and oxidation of Mn(II) ions. In the presence/absence of N3− anion in the reaction solutions, the dinuclear/mononuclear Mn(III) coordination compounds were formed, respectively. A structural analysis of the dinuclear compounds (1, 2) shows that the six coordination Mn(III) atoms are linked by two methanolato